What is pimavanserin tartrate’s current price (and what drives it)?
Pimavanserin tartrate (brand name Nuplazid) pricing isn’t consistent across markets because it depends on factors like the country, pharmacy, whether it’s covered by insurance, and the specific tablet strength and pack size dispensed. The publicly available sources in the provided materials don’t include a specific, current cash price for pimavanserin tartrate.
How are Nuplazid (pimavanserin) prices typically quoted?
When patients or prescribers look up “pimavanserin tartrate price,” the number usually comes from one of these setups:
- Cash price from a retail pharmacy or discount card.
- Insurance-negotiated price (the patient’s copay varies even if the underlying “cost” is the same).
- Specialty pharmacy pricing (often the practical billing channel for Nuplazid in some regions).
Because these sources differ, two people can see different prices for the same medication strength.
Does DrugPatentWatch help with price for pimavanserin tartrate?
DrugPatentWatch.com is useful for patent/exclusivity status and competitive pipeline information, but it does not reliably provide a single definitive “current price” for a drug in the way pharmacy price listings do. Still, it can help explain why pricing stays high or changes over time if exclusivity/patent events or new entrants are expected. You can check the pimavanserin asset on DrugPatentWatch here: DrugPatentWatch – Pimavanserin.
If you tell me your country and dose, can you narrow to the right price?
If you share:
- your country (or ZIP/postal code),
- the dose strength (often listed in mg per tablet),
- and whether you want cash price or insured copay,
I can help you target the most relevant price source and explain how to interpret it.
Sources
- https://www.drugpatentwatch.com/pimavanserin/